Ki-67 and mitotic index in triple-positive breast cancer.

被引：1
|
作者：
Urezkova, Maria Mikhailovna [1 ]
Semiglazova, Tatiana [1 ]
Artemyeva, Anna [1 ]
Kudaybergenova, Asel [1 ]
机构：
[1] NN Petrov Natl Med Res Ctr Oncol, St Petersburg, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e12551
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12551
引用
收藏
页数：3
相关论文
共 50 条
  • [41] KI-67 Expression in triple negative breast cancer (TNBC) patients and its significance
    Ouban, A.
    VIRCHOWS ARCHIV, 2021, 479 : S192 - S192
  • [42] Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer
    Munzone, Elisabetta
    Botteri, E.
    Sciandivasci, A.
    Curigliano, G.
    Nole, F.
    Mastropasqua, M.
    Rotmensz, N.
    Colleoni, M.
    Esposito, A.
    Adamoli, L.
    Luini, A.
    Goldhirsch, A.
    Viale, G.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 277 - 282
  • [43] Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer
    Elisabetta Munzone
    E. Botteri
    A. Sciandivasci
    G. Curigliano
    F. Nolè
    M. Mastropasqua
    N. Rotmensz
    M. Colleoni
    A. Esposito
    L. Adamoli
    A. Luini
    A. Goldhirsch
    G. Viale
    Breast Cancer Research and Treatment, 2012, 134 : 277 - 282
  • [44] Prognostic significance of Ki-67 index value at the primary breast tumor in recurrent breast cancer
    Nishimura, Reiki
    Osako, Tomofumi
    Nishiyama, Yasuyuki
    Tashima, Rumiko
    Nakano, Masahiro
    Fujisue, Mamiko
    Toyozumi, Yasuo
    Arima, Nobuyuki
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (06) : 1062 - 1068
  • [45] Prognostic significance of Ki-67 index value at primary breast tumor in recurrent breast cancer
    Nishimura, R.
    Osako, T.
    Nishiyama, Y.
    Tashima, R.
    Nakano, M.
    Fujisue, M.
    Toyozumi, Y.
    Arima, N.
    CANCER RESEARCH, 2013, 73
  • [46] CORRELATION OF MITOTIC RATE AND KI-67 POSITIVE CELLS IN PRIMARY MALIGNANT MELANOMAS
    OSTMEIER, H
    SUTER, L
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 91 (04) : 381 - 381
  • [47] Should triple-positive breast cancer be recognized as a distinct subtype?
    Dieci, Maria Vittoria
    Guarneri, Valentina
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (12) : 1011 - 1014
  • [48] Ki-67 Labeling Index in Patients with Estrogen-Progesterone Positive and Axillary Lymph Node Negative Breast Cancer
    Kucukzeybek, Betul Bolat
    Taskaynatan, Halil
    Sari, Aysegul Akder
    Yigit, Seyran
    Balli, Gulden
    Etit, Demet
    Yazici, Ayse
    Atahan, Murat Kemal
    Buyuktalanci, Dilara Ozyigit
    Alacacioglu, Ahmet
    Kucukzeybek, Yuksel
    KONURALP TIP DERGISI, 2018, 10 (03): : 387 - 394
  • [49] Ki-67 Proliferation Index in Breast Cancer as a Function of Assessment Method: A NordiQC Experience
    Roge, Rasmus
    Nielsen, Soren
    Riber-Hansen, Rikke
    Vyberg, Mogens
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (02) : 99 - 104
  • [50] PROLIFERATION INDEX IN VARIOUS STAGES OF BREAST-CANCER DETERMINED BY KI-67 IMMUNOSTAINING
    PENCE, JC
    KIZILBASH, AM
    KERNS, BJM
    MARKS, JR
    IGLEHART, JD
    JOURNAL OF SURGICAL ONCOLOGY, 1991, 48 (01) : 11 - 20
12345